AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells
Authors: Dietz, AB Litzow, MR Bulur, PA Vuk-Pavlovic, S
Citation: Ab. Dietz et al., Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells, CYTOTHERAPY, 3(2), 2001, pp. 97-105
Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia
Authors: Dietz, AB Litzow, MR Gastineau, DA Vuk-Pavlovic, S
Citation: Ab. Dietz et al., Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia, CROAT MED J, 42(4), 2001, pp. 428-435
Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
Authors: Porrata, LF Ingle, JN Litzow, MR Geyer, S Markovic, SN
Citation: Lf. Porrata et al., Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer, BONE MAR TR, 28(9), 2001, pp. 865-871
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation
Authors: Afessa, B Litzow, MR Tefferi, A
Citation: B. Afessa et al., Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation, BONE MAR TR, 28(5), 2001, pp. 425-434
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis
Authors: Kumar, S Dispenzieri, A Lacy, MQ Litzow, MR Gertz, MA
Citation: S. Kumar et al., High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis, BONE MAR TR, 28(4), 2001, pp. 381-385
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia
Authors: Kumar, S Chen, MG Gastineau, DA Gertz, MA Inwards, DJ Lacy, MQ Tefferi, A Litzow, MR
Citation: S. Kumar et al., Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia, BONE MAR TR, 28(10), 2001, pp. 951-956
Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation
Authors: Tefferi, A Kumar, S Wolf, RC Lacy, MQ Inwards, DJ Gloor, JM Albright, RC Kamath, PS Litzow, MR
Citation: A. Tefferi et al., Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation, BONE MAR TR, 28(10), 2001, pp. 997-999
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation
Authors: Capizzi, SA Kumar, S Huneke, NE Gertz, MA Inwards, DJ Litzow, MR Lacy, MQ Gastineau, DA Prakash, UBS Tefferi, A
Citation: Sa. Capizzi et al., Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation, BONE MAR TR, 27(12), 2001, pp. 1299-1303
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
Authors: Kumar, S Chen, MG Gastineau, DA Gertz, MA Inwards, DJ Lacy, MQ Tefferi, A Harmsen, WS Litzow, MR
Citation: S. Kumar et al., Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease, BONE MAR TR, 27(11), 2001, pp. 1133-1140
Immune reconstitution after autologous hematopoietic stem cell transplantation
Authors: Porrata, LF Litzow, MR Markovic, SN
Citation: Lf. Porrata et al., Immune reconstitution after autologous hematopoietic stem cell transplantation, MAYO CLIN P, 76(4), 2001, pp. 407-412
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Authors: Porrata, LF Gertz, MA Inwards, DJ Litzow, MR Lacy, MQ Tefferi, A Gastineau, DA Dispenzieri, A Ansell, SM Micallef, INM Geyer, SM Markovic, SN
Citation: Lf. Porrata et al., Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma, BLOOD, 98(3), 2001, pp. 579-585
The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase
Authors: Lee, SJ Klein, JP Anasetti, C Antin, JH Loberiza, FR Bowell, BJ LeMaistre, CF Litzow, MR Marks, D Waller, EK Matlack, M Giralt, S Horowitz, MM
Citation: Sj. Lee et al., The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase, BLOOD, 98(12), 2001, pp. 3205-3211
Blood and marrow transplantation
Authors: Litzow, MR
Citation: Mr. Litzow, Blood and marrow transplantation, SPR SP SURG, 2001, pp. 295-341
Acute leukemia
Authors: Litzow, MR
Citation: Mr. Litzow, Acute leukemia, PRIMARY HEMATOLOGY, 2001, pp. 193-208
Blood and marrow transplantation
Authors: Litzow, MR
Citation: Mr. Litzow, Blood and marrow transplantation, PRIMARY HEMATOLOGY, 2001, pp. 209-227
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity
Authors: Gertz, MA Lacy, MQ Bjornsson, J Litzow, MR
Citation: Ma. Gertz et al., Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity, J HEMATH ST, 9(5), 2000, pp. 635-643
Optimizing preparation of normal dendritic cells and bcr-abl(+) mature dendritic cells derived from immunomagnetically purified CD14(+) cells
Authors: Dietz, AB Bulur, PA Erickson, MR Wettstein, PJ Litzow, MR Wyatt, WA Dewald, GW Tefferi, A Pankratz, VS Vuk-Pavlovic, S
Citation: Ab. Dietz et al., Optimizing preparation of normal dendritic cells and bcr-abl(+) mature dendritic cells derived from immunomagnetically purified CD14(+) cells, J HEMATH ST, 9(1), 2000, pp. 95-101
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)
Authors: Gertz, MA Lacy, MQ Gastineau, DA Inwards, DJ Chen, MG Tefferi, A Kyle, RA Litzow, MR
Citation: Ma. Gertz et al., Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL), BONE MAR TR, 26(9), 2000, pp. 963-969
Effect of complete response on outcome following autologous stem cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Witzig, TE Lust, JA Larson, D Therneau, TM Kyle, RA Litzow, MR Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Effect of complete response on outcome following autologous stem cell transplantation for myeloma, BONE MAR TR, 26(9), 2000, pp. 979-983
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
Authors: Gertz, MA Lacy, MQ Inwards, DJ Gastineau, DA Tefferi, A Chen, MG Witzig, TE Greipp, PR Litzow, MR
Citation: Ma. Gertz et al., Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma, BONE MAR TR, 26(1), 2000, pp. 45-50
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Therneau, TM Kyle, RA Litzow, MR Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma, J CL ONCOL, 17(5), 1999, pp. 1551-1557
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 497-503
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma
Authors: Gertz, MA Lacy, MQ Inwards, DJ Chen, MG Pineda, AA Gastineau, DA Greipp, PR Lust, JA Tefferi, A Witzig, TE Kyle, RA Litzow, MR
Citation: Ma. Gertz et al., Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma, BONE MAR TR, 23(3), 1999, pp. 221-226
Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Autologous stem cell transplantation for relapsed and primary refractory myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Autologous stem cell transplantation for relapsed and primary refractory myeloma, BONE MAR TR, 23(12), 1999, pp. 1267-1272
Risultati: 1-25 | 26-26